Government Medical College And Hospital Chandigarh Inj Midazolam 1mg/ml 5ml vial Tender 2026

Tender Overview

Government Medical College And Hospital, Chandigarh invites bids for the supply of Inj. Midazolam 1mg/ml, 5ml vial (IM, IV) with supply-only terms. Estimated value and quantity are not disclosed, but the EMD is ₹17,500. The tender emphasizes hospital-rate pricing, dual-channel GMP/WHO GMP or ISO/QMS compliance, and batch-specific test reports stamped with “GMCH -32, Chandigarh supply not for sale.” This procurement requires principal-manufacturer documentation and distributor authorization where applicable. Key differentiators include mandated test reports from approved drug laboratories and an intricate affidavit from the principal manufacturer. Bidders must provide complete product specifications, packing details, and ensure conformity to Indian drug regulations. The tender is targeted at suppliers capable of meeting hospital-grade pharmaceutical standards within Chandigarh, with compliance obligations clearly defined in Annexure I. The scope is to ensure ready-to-dispatch drug supply with batch traceability, packaging clarity, and verification tests. Overall, this is a regulated pharmaceutical supply tender with strict documentation and compliance requirements.

Technical Specifications & Requirements

• Product: Inj. Midazolam 1mg/ml, 5ml vial (IM/IV)
• Volume/Concentration: 1 mg per ml in a 5 ml vial
• Packaging: Complete specification and packing details to be stated by bidder, including product label
• Manufacturer Licenses: Valid manufacturing license issued by State licensing authority for the quoted item
• GMP/ISO: GMP under Schedule M or revised Schedule M (Drug & Cosmetics Act) or WHO GMP; if license from State Food Licensing, provide ISO/QMS; if Medical Devices 2017 license, QMS/GMP/ISO may not be required from Principal Manufacturer
• Distributor/Authorised Dealer: If applicable, submit a bid-specific authorization from principal manufacturer
• Pricing Assurance: Certificate that quoted rates are hospital rates and not higher than other government/private entities
• Batch Tests: Test reports for each batch from an approved Drug Controller laboratory; stamping: “GMCH -32, Chandigarh supply not for sale” on each batch
• Affidavit: Original affidavit from principal manufacturer on Rs 100 non-judicial stamp paper
• Financial Credentials: Annual turnover evidence for 3 of the last 4 financial years; solvency certificate from bank
• Annexure I: Compliance affidavit detailing non-blacklisting and statutory adherence
• Documentation: All GeM STC documents in addition to item specifications

Terms, Conditions & Eligibility

• EMD: ₹17,500 (to be provided via appropriate instrument)
• Experience/Turnover: Annual turnover details required for 3 of the last 4 financial years; evidence of financial stability
• Delivery/Availability: Not explicitly stated; supplier must align with hospital supply timelines and batch-testing before dispatch
• Payment Terms: Not specified in available text; presumably per GeM terms and hospital policy
• Documents to Submit: Valid manufacturing license, GMP/WHO GMP or ISO/QMS certificates, principal-manufacturer affidavit, distributor authorization if applicable, hospital-rate certificate, batch test reports, stamping, solvency certificate, GSTIN, PAN, and sample BID compliance
• Warranty/Quality: GMP/ISO/QMS compliance and batch quality testing are mandatory; stamp and lab tests required for every delivery
• Penalties: Not listed; penalties typically align with drug-supply standards and batch-test failures
• Compliance Scope: Ensure all statutory Acts cited in Annexure I are followed (Drugs & Cosmetics Act, GST, etc.)